Centiva Capital’s AstraZeneca AZN Stock Holding History

Centiva Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-22,500	Closed	-$3.03M	–	1773
2023 Q4	$3.03M	Hold	22,500	–	–	0.07%	257
2023 Q3	$3.05M	Buy	22,500 +2,500	+13%	+$341K	0.07%	267
2023 Q2	$2.86M	Hold	20,000	–	–	0.06%	293
2023 Q1	$2.78M	Buy	+20,000	New	+$2.69M	0.07%	309
2021 Q3	–	Sell	-50,000	Closed	-$5.99M	–	1270
2021 Q2	$5.99M	Sell	50,000 -22,500	-31%	-$2.47M	0.14%	118
2021 Q1	$7.21M	Buy	72,500 +50,000	+222%	+$5.03M	0.28%	62
2020 Q4	$2.25M	Buy	+22,500	New	+$2.38M	0.09%	137

Other funds holding AZN

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

Centiva Capital's AZN Position: Q1 2026 in Review

Centiva Capital sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 3,098 shares — an estimated $570K sold.

Centiva Capital first reported a position in AZN in Q3 2019 and held it in 12 quarters. The position peaked at $1.6M in Q1 2022. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Centiva Capital reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Centiva Capital sold 3,098 AstraZeneca shares in Q1 2026, an estimated $570K.
Centiva Capital first reported a position in AstraZeneca in Q3 2019 and held it in 12 quarters.
Centiva Capital's AstraZeneca position peaked at $1.6M in Q1 2022.
1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.